Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 16, 2021; 9(35): 10871-10883
Published online Dec 16, 2021. doi: 10.12998/wjcc.v9.i35.10871
Published online Dec 16, 2021. doi: 10.12998/wjcc.v9.i35.10871
Group | Low CONUT | Medium CONUT | High CONUT | P value |
HB (g/L) | 122.6 ± 25.5 | 96.8 ± 26.52 | 89.2 ± 17.9 | < 0.001a; < 0.001b; 0.074c |
WBC (cells/mm3) | 4.95 (3.24-6.54) | 4.63 (3.43-6.94) | 4.8 ± 3.3 | 0.101 |
PLT (cells/mm3) | 113.0 (58.0-116.5) | 105.0 (46.5-166.0) | 111.1 ± 79.1 | 0.493 |
Albumen (g/L) | 38.8 ± 4.53 | 31.8 (29.0-34.4) | 26.34 ± 2.65 | < 0.001a; < 0.001b; < 0.001c |
Total cholesterol (mg/dL) | 148.08 (117.75-178.81) | 102.67 (81.39-113.68) | 80.7 ± 29.81 | < 0.001a; < 0.001b; < 0.001c |
Total lymphocytes (cells/mm3) | 1190 (860-1730) | 700 (440-1170) | 530(380-770) | < 0.001a; < 0.001b; < 0.001c |
Intraoperative data | ||||
Packed red cell transfusion (units) | 6.0 (4.0-10.0) | 10.0 (8.0-12.0) | 10.0 (8.0-16.0) | < 0.001a; < 0.001b; 0.158c |
Frozen plasma transfusion (mL) | 1800.0 (1000.0-2100.0) | 2000.0 (1600.0-2000.0) | 2078.6 ± 638.4 | 0.180a; 0.018b; 0.319c |
Blood loss (mL) | 1600.0 (800.0-2000.0) | 2000.0 (1500.0-2400.0) | 2000.0 (1500.0-2400.0) | 0.069a; 0.004b; 1.00c |
Anhepatic phase (min) | 42.0 (40.0-50.0) | 45.0 (37.0-50.0) | 45.0 ± 11.4 | 0.849 |
Operation time (h) | 7.5 (6.7-8.3) | 7.5 (7.0-8.4) | 7.5 (6.6-9.0) | 0.542 |
Postoperative data | ||||
Time of ventilator extubation (h) | 6.0 (4.0-9.0) | 10.5 (5.0-31.4) | 6.5 (3.5-24.0) | 0.237 |
ICU stay (d) | 3.0 (2.0-4.0) | 4.0 (3.0-4.9) | 3.0 (3.0-4.96) | < 0.001a; 0.049b; 1.00c |
hospital stay (d) | 25.0 (21.0-30.0) | 35.0 (26.0-37.3) | 33.0 (27.0-38.0) | < 0.001a; < 0.001b; 0.94c |
Day 7 TBil (μmol/L) | 30.0 (18.09-43.5) | 48.0 (27.5-75.5) | 55.6± 37.9 | 0.21a; 0.01b; 1.00c |
Day 14 TBil (µmol/L) | 19.0 (13.25-32.0) | 33.0 (19.0-51.9) | 42.0 (22.0-72.0) | 0.01a; < 0.001b; 1.00c |
Day 7 AST (U/L) | 27.0 (19.5-35.8) | 24.0 (15.5-39.1) | 26.3 ± 16.5 | 0.180 |
Day 14 AST (U/L) | 25.0 (20.1-38.0) | 26.0 (18-0-39.5) | 26.0 (17.0-40.0) | 0.809 |
Day 7 ALT (U/L) | 79.0 (56.5-104.0) | 65.0 (39.0-97.5) | 57.0 (34.0-93.0) | 0.685a; 0.019b; 0.069c |
Day 14 ALT (U/L) | 61.0 (35.0-81.5) | 47.0 (32.5-72.3) | 43.0 (21.0-70.0) | 0.153 |
Day 7 INR | 1.31 (1.14-1.47) | 1.30 (1.15-1.51) | 1.27 (1.15-1.34) | 0.719 |
Day 14 INR | 1.26 (1.08-1.27) | 1.34 (1.15-1.51) | 1.34 (1.13-1.71) | 0.499 |
Day 7 Cr (μmol/L) | 55.0 (46.2-63.0) | 62.0 (49.0-80.5) | 57.0 (40.0-71.0) | 0.097 |
Day 14 Cr (μmol/L) | 58.0 (45.5-68.0) | 62.0 (49.0-73.5) | 59.1 ± 23.4 | 0.161 |
Day 7 BUN (mmol/L) | 7.71 (5.04-9.45) | 8.2 (6.1-11.5) | 7.5 (5.8-10.7) | 0.71 |
Day 14 BUN (mmol/L) | 5.28(4.30-6.75) | 7.13 (5.20-9.52) | 6.0 (4.6-8.9) | 0.13a; 0.01b; 0.796c |
- Citation: Dai X, Gao B, Zhang XX, Li J, Jiang WT. Value of the controlling nutritional status score and psoas muscle thickness per height in predicting prognosis in liver transplantation. World J Clin Cases 2021; 9(35): 10871-10883
- URL: https://www.wjgnet.com/2307-8960/full/v9/i35/10871.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i35.10871